Anti-obesity effect of irreversible MAO-B inhibitors in patients with Parkinson's disease
{{output}}
We read with great interest the report on the new anti-obesity potential in mice models of reversible monoamine oxidase B inhibitors by Moonsun et al., as opposed to the lack of such effects observed with irreversible MAO-B inhibitors (iMAO-Bi). Our research a... ...
